Results 11 to 20 of about 26,692,564 (286)

Cost-Effectiveness Analysis [PDF]

open access: yes, 2019
Abstract Cost-effectiveness analysis (CEA) is a form of economic evaluation concerned with efficiency: that is, with achieving the most for the resources (“value for money”). This chapter explains the appeal and relevance of CEA and describes its use in localized and strategic decision-making.
Lauer, Jeremy   +2 more
core   +4 more sources

A Bayesian approach to stochastic cost-effectiveness analysis [PDF]

open access: yes, 2001
The aim of this paper is to discuss the use of Bayesian methods in cost-effectiveness analysis (CEA) and the common ground between Bayesian and traditional frequentist approaches.
Briggs, A.
core   +8 more sources

Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury

open access: yesClinicoEconomics and Outcomes Research, 2010
Rashid Kazerooni1, Mark Bounthavong1,21Pharmacoeconomics/Formulary Management, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA; 2UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA, USAObjective: There has been ...
Rashid Kazerooni, Mark Bounthavong
doaj   +1 more source

Methodological issues in the analysis of individual- and aggregate-participant level data for cost effectiveness analysis [PDF]

open access: yes, 2012
Health care economic evaluations assess the costs and consequences of competing interventions, programmes or services. Such assessments use a decision model, with parameters informed by available evidence.
Saramago Goncalves, Pedro
core   +6 more sources

Decision Analysis and Cost-Effectiveness Analysis [PDF]

open access: yesSeminars in Spine Surgery, 2009
Healthcare decision-making can be complex, often requiring decision makers to weigh serious trade-offs, consider patients' values, and incorporate evidence in the face of uncertainty. Medical decisions are made implicitly by clinicians and other decision-makers on a daily basis. Decisions based largely on personal experience are subject to many biases.
Hilary F, Ryder   +3 more
openaire   +2 more sources

Systematic review of economic evaluation studies in psychiatric pharmacogenomics

open access: yesEuropean Psychiatry, 2021
Introduction Nowadays, many relevant gene-drug associations have been discovered, but pharmacogenomics (PGx)-guided treatment needs to be cost-effective as well as clinically beneficial to be incorporated into standard health-care.
C. Mitropoulou   +7 more
doaj   +1 more source

Cost-effectiveness of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in patients with endothelial dysfunction in India

open access: yesIndian Journal of Ophthalmology, 2021
Purpose: The aim of this study was to compare the cost-effectiveness and perform cost-utility analysis of Descemet stripping automated endothelial keratoplasty (DSAEK) vs. penetrating keratoplasty (PK) in Indian population.
Pooja Shah   +4 more
doaj   +1 more source

Economic Evaluation of Cataract: A Systematic Mapping Review

open access: yesOphthalmology and Therapy, 2023
Introduction The purpose of this article was to ascertain the existing literature and find the gaps in economic evaluations of cataracts. Methods Systematic methods were used to search and collect the published literature on economic evaluations of ...
José Ginel   +5 more
doaj   +1 more source

The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation

open access: yesTrials, 2021
Background Different approaches have been used by dentists to base their decision. Among them, there are the aesthetical issues that may lead to more interventionist approaches. Indeed, using a more interventionist strategy (the World Dental Federation -
Raíza Dias Freitas   +14 more
doaj   +1 more source

Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy

open access: yesClinicoEconomics and Outcomes Research, 2021
Gianni Ghetti,1 Maria Claudia D’Avella,2 Lorenzo Pradelli1 1Department of Health Economics and Outcome Research, AdRes, Turin, Italy; 2Department of Market Access, Sanofi, Milan, ItalyCorrespondence: Gianni GhettiDepartment of Health Economics and ...
Ghetti G, D'Avella MC, Pradelli L
doaj  

Home - About - Disclaimer - Privacy